Prof. Dr. Ken Herrmann is a leading expert in nuclear medicine, currently serving as the Chair of the Department of Nuclear Medicine at University of Duisburg-Essen (UDE), Germany. His research focuses on the development and clinical application of radiopharmaceuticals for the diagnosis and treatment of various cancers, including thyroid carcinoma, endocrine tumours, and prostate cancer. Prof. Herrmann's work emphasizes the optimization of PET and PET/CT imaging techniques to enhance clinical outcomes. He has contributed significantly to the field through numerous publications and has been involved in several high-profile research projects. Additionally, he holds leadership roles in professional organizations, furthering advancements in oncologic nuclear medicine.